nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—kidney cancer	0.444	1	CbGaD
Methoxsalen—CYP1A1—Erlotinib—kidney cancer	0.0608	0.179	CbGbCtD
Methoxsalen—CYP3A4—Everolimus—kidney cancer	0.0562	0.165	CbGbCtD
Methoxsalen—CYP1A2—Pazopanib—kidney cancer	0.038	0.112	CbGbCtD
Methoxsalen—CYP3A4—Temsirolimus—kidney cancer	0.0379	0.112	CbGbCtD
Methoxsalen—CYP1A2—Erlotinib—kidney cancer	0.0271	0.0799	CbGbCtD
Methoxsalen—CYP1A2—Sorafenib—kidney cancer	0.0221	0.0649	CbGbCtD
Methoxsalen—CYP3A4—Pazopanib—kidney cancer	0.0199	0.0586	CbGbCtD
Methoxsalen—CYP3A4—Erlotinib—kidney cancer	0.0142	0.0418	CbGbCtD
Methoxsalen—CYP3A4—Paclitaxel—kidney cancer	0.013	0.0383	CbGbCtD
Methoxsalen—CYP3A4—Sorafenib—kidney cancer	0.0116	0.034	CbGbCtD
Methoxsalen—CYP3A4—Vinblastine—kidney cancer	0.0114	0.0336	CbGbCtD
Methoxsalen—CYP3A4—Vincristine—kidney cancer	0.0112	0.033	CbGbCtD
Methoxsalen—CYP3A4—Sunitinib—kidney cancer	0.00937	0.0276	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—kidney cancer	0.00702	0.0206	CbGbCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—kidney cancer	0.000594	0.00406	CcSEcCtD
Methoxsalen—Oedema—Temsirolimus—kidney cancer	0.000571	0.0039	CcSEcCtD
Methoxsalen—Infection—Temsirolimus—kidney cancer	0.000567	0.00388	CcSEcCtD
Methoxsalen—Inflammation—Capecitabine—kidney cancer	0.000565	0.00386	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—kidney cancer	0.000562	0.00384	CcSEcCtD
Methoxsalen—Depression—Sunitinib—kidney cancer	0.000554	0.00379	CcSEcCtD
Methoxsalen—Skin disorder—Temsirolimus—kidney cancer	0.000554	0.00379	CcSEcCtD
Methoxsalen—Oedema—Pazopanib—kidney cancer	0.000538	0.00368	CcSEcCtD
Methoxsalen—Infection—Pazopanib—kidney cancer	0.000534	0.00365	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—kidney cancer	0.000523	0.00358	CcSEcCtD
Methoxsalen—Skin exfoliation—Capecitabine—kidney cancer	0.000523	0.00358	CcSEcCtD
Methoxsalen—Skin disorder—Pazopanib—kidney cancer	0.000522	0.00357	CcSEcCtD
Methoxsalen—Erythema—Everolimus—kidney cancer	0.00052	0.00356	CcSEcCtD
Methoxsalen—Insomnia—Temsirolimus—kidney cancer	0.000516	0.00353	CcSEcCtD
Methoxsalen—Arrhythmia—Erlotinib—kidney cancer	0.000515	0.00352	CcSEcCtD
Methoxsalen—Dysgeusia—Everolimus—kidney cancer	0.000509	0.00348	CcSEcCtD
Methoxsalen—Erythema—Erlotinib—kidney cancer	0.000502	0.00343	CcSEcCtD
Methoxsalen—Muscle spasms—Everolimus—kidney cancer	0.0005	0.00342	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000493	0.00337	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—kidney cancer	0.00049	0.00335	CcSEcCtD
Methoxsalen—Insomnia—Pazopanib—kidney cancer	0.000486	0.00333	CcSEcCtD
Methoxsalen—Ill-defined disorder—Vinblastine—kidney cancer	0.000484	0.00331	CcSEcCtD
Methoxsalen—Ill-defined disorder—Everolimus—kidney cancer	0.000483	0.0033	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Vincristine—kidney cancer	0.000481	0.00329	CcSEcCtD
Methoxsalen—Dyspepsia—Pazopanib—kidney cancer	0.000473	0.00324	CcSEcCtD
Methoxsalen—Malaise—Vinblastine—kidney cancer	0.000471	0.00322	CcSEcCtD
Methoxsalen—Vertigo—Vinblastine—kidney cancer	0.000469	0.00321	CcSEcCtD
Methoxsalen—Malaise—Everolimus—kidney cancer	0.000469	0.00321	CcSEcCtD
Methoxsalen—Depression—Vincristine—kidney cancer	0.000469	0.00321	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000464	0.00318	CcSEcCtD
Methoxsalen—Arrhythmia—Sorafenib—kidney cancer	0.000463	0.00317	CcSEcCtD
Methoxsalen—Erythema—Sorafenib—kidney cancer	0.000451	0.00309	CcSEcCtD
Methoxsalen—Body temperature increased—Temsirolimus—kidney cancer	0.000451	0.00309	CcSEcCtD
Methoxsalen—Arrhythmia—Sunitinib—kidney cancer	0.000446	0.00305	CcSEcCtD
Methoxsalen—Dry skin—Paclitaxel—kidney cancer	0.000444	0.00304	CcSEcCtD
Methoxsalen—Dysgeusia—Sorafenib—kidney cancer	0.000442	0.00302	CcSEcCtD
Methoxsalen—Discomfort—Vinblastine—kidney cancer	0.000439	0.003	CcSEcCtD
Methoxsalen—Discomfort—Everolimus—kidney cancer	0.000438	0.00299	CcSEcCtD
Methoxsalen—Erythema—Sunitinib—kidney cancer	0.000434	0.00297	CcSEcCtD
Methoxsalen—Muscle spasms—Sorafenib—kidney cancer	0.000434	0.00297	CcSEcCtD
Methoxsalen—Dysgeusia—Sunitinib—kidney cancer	0.000425	0.00291	CcSEcCtD
Methoxsalen—Oedema—Everolimus—kidney cancer	0.000425	0.0029	CcSEcCtD
Methoxsalen—Infection—Everolimus—kidney cancer	0.000422	0.00288	CcSEcCtD
Methoxsalen—Hypersensitivity—Temsirolimus—kidney cancer	0.00042	0.00288	CcSEcCtD
Methoxsalen—Muscle spasms—Sunitinib—kidney cancer	0.000418	0.00286	CcSEcCtD
Methoxsalen—Dermatitis bullous—Capecitabine—kidney cancer	0.000416	0.00285	CcSEcCtD
Methoxsalen—Skin disorder—Everolimus—kidney cancer	0.000412	0.00282	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—kidney cancer	0.000411	0.00281	CcSEcCtD
Methoxsalen—Oedema—Erlotinib—kidney cancer	0.00041	0.0028	CcSEcCtD
Methoxsalen—Infection—Erlotinib—kidney cancer	0.000407	0.00278	CcSEcCtD
Methoxsalen—Pruritus—Temsirolimus—kidney cancer	0.000404	0.00276	CcSEcCtD
Methoxsalen—Skin disorder—Erlotinib—kidney cancer	0.000398	0.00272	CcSEcCtD
Methoxsalen—Hypotension—Everolimus—kidney cancer	0.000397	0.00271	CcSEcCtD
Methoxsalen—Insomnia—Everolimus—kidney cancer	0.000384	0.00263	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—kidney cancer	0.000383	0.00262	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000382	0.00262	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—kidney cancer	0.000382	0.00261	CcSEcCtD
Methoxsalen—Pruritus—Pazopanib—kidney cancer	0.00038	0.0026	CcSEcCtD
Methoxsalen—Dizziness—Temsirolimus—kidney cancer	0.000377	0.00258	CcSEcCtD
Methoxsalen—Dyspepsia—Everolimus—kidney cancer	0.000374	0.00256	CcSEcCtD
Methoxsalen—Depression—Paclitaxel—kidney cancer	0.000372	0.00255	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—kidney cancer	0.000371	0.00254	CcSEcCtD
Methoxsalen—Insomnia—Erlotinib—kidney cancer	0.00037	0.00253	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Everolimus—kidney cancer	0.000366	0.00251	CcSEcCtD
Methoxsalen—Infection—Sorafenib—kidney cancer	0.000366	0.0025	CcSEcCtD
Methoxsalen—Dry skin—Capecitabine—kidney cancer	0.000365	0.00249	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—kidney cancer	0.000364	0.00249	CcSEcCtD
Methoxsalen—Dyspepsia—Erlotinib—kidney cancer	0.000361	0.00247	CcSEcCtD
Methoxsalen—Rash—Temsirolimus—kidney cancer	0.00036	0.00246	CcSEcCtD
Methoxsalen—Dermatitis—Temsirolimus—kidney cancer	0.000359	0.00246	CcSEcCtD
Methoxsalen—Skin disorder—Sorafenib—kidney cancer	0.000358	0.00245	CcSEcCtD
Methoxsalen—Arrhythmia—Gemcitabine—kidney cancer	0.000358	0.00245	CcSEcCtD
Methoxsalen—Headache—Temsirolimus—kidney cancer	0.000358	0.00245	CcSEcCtD
Methoxsalen—Dizziness—Pazopanib—kidney cancer	0.000356	0.00243	CcSEcCtD
Methoxsalen—Oedema—Sunitinib—kidney cancer	0.000355	0.00243	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000354	0.00242	CcSEcCtD
Methoxsalen—Infection—Sunitinib—kidney cancer	0.000352	0.00241	CcSEcCtD
Methoxsalen—Feeling abnormal—Vinblastine—kidney cancer	0.000351	0.0024	CcSEcCtD
Methoxsalen—Feeling abnormal—Everolimus—kidney cancer	0.00035	0.00239	CcSEcCtD
Methoxsalen—Erythema—Gemcitabine—kidney cancer	0.000349	0.00238	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—kidney cancer	0.000346	0.00237	CcSEcCtD
Methoxsalen—Skin disorder—Sunitinib—kidney cancer	0.000344	0.00236	CcSEcCtD
Methoxsalen—Rash—Pazopanib—kidney cancer	0.000339	0.00232	CcSEcCtD
Methoxsalen—Nausea—Temsirolimus—kidney cancer	0.000339	0.00232	CcSEcCtD
Methoxsalen—Dermatitis—Pazopanib—kidney cancer	0.000339	0.00232	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—kidney cancer	0.000337	0.00231	CcSEcCtD
Methoxsalen—Headache—Pazopanib—kidney cancer	0.000337	0.0023	CcSEcCtD
Methoxsalen—Oedema—Dactinomycin—kidney cancer	0.000336	0.0023	CcSEcCtD
Methoxsalen—Body temperature increased—Everolimus—kidney cancer	0.000336	0.0023	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—kidney cancer	0.000333	0.00228	CcSEcCtD
Methoxsalen—Vertigo—Vincristine—kidney cancer	0.00033	0.00226	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000324	0.00222	CcSEcCtD
Methoxsalen—Dyspepsia—Sorafenib—kidney cancer	0.000324	0.00222	CcSEcCtD
Methoxsalen—Body temperature increased—Erlotinib—kidney cancer	0.000324	0.00221	CcSEcCtD
Methoxsalen—Ill-defined disorder—Gemcitabine—kidney cancer	0.000323	0.00221	CcSEcCtD
Methoxsalen—Insomnia—Sunitinib—kidney cancer	0.000321	0.00219	CcSEcCtD
Methoxsalen—Nausea—Pazopanib—kidney cancer	0.000319	0.00218	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000318	0.00218	CcSEcCtD
Methoxsalen—Malaise—Gemcitabine—kidney cancer	0.000314	0.00215	CcSEcCtD
Methoxsalen—Hypersensitivity—Vinblastine—kidney cancer	0.000314	0.00215	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Capecitabine—kidney cancer	0.000314	0.00215	CcSEcCtD
Methoxsalen—Hypersensitivity—Everolimus—kidney cancer	0.000313	0.00214	CcSEcCtD
Methoxsalen—Dyspepsia—Sunitinib—kidney cancer	0.000312	0.00213	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000306	0.00209	CcSEcCtD
Methoxsalen—Depression—Capecitabine—kidney cancer	0.000306	0.00209	CcSEcCtD
Methoxsalen—Pruritus—Everolimus—kidney cancer	0.0003	0.00205	CcSEcCtD
Methoxsalen—Oedema—Vincristine—kidney cancer	0.0003	0.00205	CcSEcCtD
Methoxsalen—Arrhythmia—Paclitaxel—kidney cancer	0.0003	0.00205	CcSEcCtD
Methoxsalen—Infection—Vincristine—kidney cancer	0.000298	0.00204	CcSEcCtD
Methoxsalen—Discomfort—Gemcitabine—kidney cancer	0.000293	0.00201	CcSEcCtD
Methoxsalen—Urticaria—Sorafenib—kidney cancer	0.000293	0.002	CcSEcCtD
Methoxsalen—Erythema—Paclitaxel—kidney cancer	0.000292	0.002	CcSEcCtD
Methoxsalen—Body temperature increased—Sorafenib—kidney cancer	0.000291	0.00199	CcSEcCtD
Methoxsalen—Pruritus—Erlotinib—kidney cancer	0.00029	0.00198	CcSEcCtD
Methoxsalen—Tension—Paclitaxel—kidney cancer	0.000286	0.00196	CcSEcCtD
Methoxsalen—Dysgeusia—Paclitaxel—kidney cancer	0.000286	0.00196	CcSEcCtD
Methoxsalen—Oedema—Gemcitabine—kidney cancer	0.000285	0.00195	CcSEcCtD
Methoxsalen—Nervousness—Paclitaxel—kidney cancer	0.000283	0.00194	CcSEcCtD
Methoxsalen—Infection—Gemcitabine—kidney cancer	0.000283	0.00193	CcSEcCtD
Methoxsalen—Dizziness—Vinblastine—kidney cancer	0.000282	0.00193	CcSEcCtD
Methoxsalen—Dizziness—Everolimus—kidney cancer	0.000281	0.00192	CcSEcCtD
Methoxsalen—Muscle spasms—Paclitaxel—kidney cancer	0.000281	0.00192	CcSEcCtD
Methoxsalen—Body temperature increased—Sunitinib—kidney cancer	0.00028	0.00192	CcSEcCtD
Methoxsalen—Hypotension—Vincristine—kidney cancer	0.00028	0.00192	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—kidney cancer	0.000277	0.00189	CcSEcCtD
Methoxsalen—Skin disorder—Gemcitabine—kidney cancer	0.000276	0.00189	CcSEcCtD
Methoxsalen—Hypersensitivity—Sorafenib—kidney cancer	0.000271	0.00186	CcSEcCtD
Methoxsalen—Insomnia—Vincristine—kidney cancer	0.000271	0.00186	CcSEcCtD
Methoxsalen—Dizziness—Erlotinib—kidney cancer	0.000271	0.00185	CcSEcCtD
Methoxsalen—Ill-defined disorder—Paclitaxel—kidney cancer	0.000271	0.00185	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—kidney cancer	0.000268	0.00183	CcSEcCtD
Methoxsalen—Rash—Everolimus—kidney cancer	0.000268	0.00183	CcSEcCtD
Methoxsalen—Dermatitis—Everolimus—kidney cancer	0.000267	0.00183	CcSEcCtD
Methoxsalen—Headache—Vinblastine—kidney cancer	0.000267	0.00183	CcSEcCtD
Methoxsalen—Headache—Everolimus—kidney cancer	0.000266	0.00182	CcSEcCtD
Methoxsalen—Hypotension—Gemcitabine—kidney cancer	0.000266	0.00182	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—kidney cancer	0.000265	0.00182	CcSEcCtD
Methoxsalen—Malaise—Paclitaxel—kidney cancer	0.000263	0.0018	CcSEcCtD
Methoxsalen—Vertigo—Paclitaxel—kidney cancer	0.000262	0.00179	CcSEcCtD
Methoxsalen—Hypersensitivity—Sunitinib—kidney cancer	0.000261	0.00179	CcSEcCtD
Methoxsalen—Pruritus—Sorafenib—kidney cancer	0.000261	0.00178	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Vincristine—kidney cancer	0.000259	0.00177	CcSEcCtD
Methoxsalen—Rash—Erlotinib—kidney cancer	0.000258	0.00177	CcSEcCtD
Methoxsalen—Dermatitis—Erlotinib—kidney cancer	0.000258	0.00176	CcSEcCtD
Methoxsalen—Insomnia—Gemcitabine—kidney cancer	0.000257	0.00176	CcSEcCtD
Methoxsalen—Headache—Erlotinib—kidney cancer	0.000257	0.00176	CcSEcCtD
Methoxsalen—Nausea—Vinblastine—kidney cancer	0.000253	0.00173	CcSEcCtD
Methoxsalen—Nausea—Everolimus—kidney cancer	0.000252	0.00172	CcSEcCtD
Methoxsalen—Pruritus—Sunitinib—kidney cancer	0.000251	0.00172	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—kidney cancer	0.000247	0.00169	CcSEcCtD
Methoxsalen—Arrhythmia—Capecitabine—kidney cancer	0.000246	0.00168	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000246	0.00168	CcSEcCtD
Methoxsalen—Discomfort—Paclitaxel—kidney cancer	0.000246	0.00168	CcSEcCtD
Methoxsalen—Dizziness—Sorafenib—kidney cancer	0.000244	0.00167	CcSEcCtD
Methoxsalen—Nausea—Erlotinib—kidney cancer	0.000243	0.00166	CcSEcCtD
Methoxsalen—Erythema—Capecitabine—kidney cancer	0.00024	0.00164	CcSEcCtD
Methoxsalen—Oedema—Paclitaxel—kidney cancer	0.000238	0.00163	CcSEcCtD
Methoxsalen—Body temperature increased—Vincristine—kidney cancer	0.000237	0.00162	CcSEcCtD
Methoxsalen—Infection—Paclitaxel—kidney cancer	0.000237	0.00162	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—kidney cancer	0.000235	0.00161	CcSEcCtD
Methoxsalen—Dysgeusia—Capecitabine—kidney cancer	0.000235	0.0016	CcSEcCtD
Methoxsalen—Dizziness—Sunitinib—kidney cancer	0.000234	0.0016	CcSEcCtD
Methoxsalen—Feeling abnormal—Gemcitabine—kidney cancer	0.000234	0.0016	CcSEcCtD
Methoxsalen—Rash—Sorafenib—kidney cancer	0.000232	0.00159	CcSEcCtD
Methoxsalen—Dermatitis—Sorafenib—kidney cancer	0.000232	0.00159	CcSEcCtD
Methoxsalen—Skin disorder—Paclitaxel—kidney cancer	0.000231	0.00158	CcSEcCtD
Methoxsalen—Headache—Sorafenib—kidney cancer	0.000231	0.00158	CcSEcCtD
Methoxsalen—Muscle spasms—Capecitabine—kidney cancer	0.00023	0.00158	CcSEcCtD
Methoxsalen—Body temperature increased—Gemcitabine—kidney cancer	0.000225	0.00154	CcSEcCtD
Methoxsalen—Rash—Sunitinib—kidney cancer	0.000224	0.00153	CcSEcCtD
Methoxsalen—Dermatitis—Sunitinib—kidney cancer	0.000223	0.00153	CcSEcCtD
Methoxsalen—Hypotension—Paclitaxel—kidney cancer	0.000223	0.00152	CcSEcCtD
Methoxsalen—Ill-defined disorder—Capecitabine—kidney cancer	0.000222	0.00152	CcSEcCtD
Methoxsalen—Headache—Sunitinib—kidney cancer	0.000222	0.00152	CcSEcCtD
Methoxsalen—Hypersensitivity—Vincristine—kidney cancer	0.000221	0.00151	CcSEcCtD
Methoxsalen—Nausea—Sorafenib—kidney cancer	0.000219	0.0015	CcSEcCtD
Methoxsalen—Malaise—Capecitabine—kidney cancer	0.000216	0.00148	CcSEcCtD
Methoxsalen—Insomnia—Paclitaxel—kidney cancer	0.000215	0.00147	CcSEcCtD
Methoxsalen—Vertigo—Capecitabine—kidney cancer	0.000215	0.00147	CcSEcCtD
Methoxsalen—Rash—Dactinomycin—kidney cancer	0.000212	0.00145	CcSEcCtD
Methoxsalen—Nausea—Sunitinib—kidney cancer	0.000211	0.00144	CcSEcCtD
Methoxsalen—Dyspepsia—Paclitaxel—kidney cancer	0.00021	0.00143	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000206	0.00141	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000202	0.00138	CcSEcCtD
Methoxsalen—Discomfort—Capecitabine—kidney cancer	0.000201	0.00138	CcSEcCtD
Methoxsalen—Pruritus—Gemcitabine—kidney cancer	0.000201	0.00138	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—kidney cancer	0.000199	0.00136	CcSEcCtD
Methoxsalen—Dizziness—Vincristine—kidney cancer	0.000198	0.00136	CcSEcCtD
Methoxsalen—Feeling abnormal—Paclitaxel—kidney cancer	0.000196	0.00134	CcSEcCtD
Methoxsalen—Oedema—Capecitabine—kidney cancer	0.000195	0.00134	CcSEcCtD
Methoxsalen—Infection—Capecitabine—kidney cancer	0.000194	0.00133	CcSEcCtD
Methoxsalen—Skin disorder—Capecitabine—kidney cancer	0.00019	0.0013	CcSEcCtD
Methoxsalen—Urticaria—Paclitaxel—kidney cancer	0.000189	0.00129	CcSEcCtD
Methoxsalen—Rash—Vincristine—kidney cancer	0.000189	0.00129	CcSEcCtD
Methoxsalen—Dermatitis—Vincristine—kidney cancer	0.000189	0.00129	CcSEcCtD
Methoxsalen—Body temperature increased—Paclitaxel—kidney cancer	0.000188	0.00129	CcSEcCtD
Methoxsalen—Headache—Vincristine—kidney cancer	0.000188	0.00129	CcSEcCtD
Methoxsalen—Hypotension—Capecitabine—kidney cancer	0.000183	0.00125	CcSEcCtD
Methoxsalen—Rash—Gemcitabine—kidney cancer	0.000179	0.00123	CcSEcCtD
Methoxsalen—Dermatitis—Gemcitabine—kidney cancer	0.000179	0.00123	CcSEcCtD
Methoxsalen—Headache—Gemcitabine—kidney cancer	0.000178	0.00122	CcSEcCtD
Methoxsalen—Nausea—Vincristine—kidney cancer	0.000178	0.00122	CcSEcCtD
Methoxsalen—Insomnia—Capecitabine—kidney cancer	0.000177	0.00121	CcSEcCtD
Methoxsalen—Hypersensitivity—Paclitaxel—kidney cancer	0.000175	0.0012	CcSEcCtD
Methoxsalen—Dyspepsia—Capecitabine—kidney cancer	0.000172	0.00118	CcSEcCtD
Methoxsalen—Nausea—Gemcitabine—kidney cancer	0.000169	0.00116	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000169	0.00115	CcSEcCtD
Methoxsalen—Pruritus—Paclitaxel—kidney cancer	0.000169	0.00115	CcSEcCtD
Methoxsalen—Feeling abnormal—Capecitabine—kidney cancer	0.000161	0.0011	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—kidney cancer	0.000158	0.00108	CcSEcCtD
Methoxsalen—Dizziness—Paclitaxel—kidney cancer	0.000158	0.00108	CcSEcCtD
Methoxsalen—Urticaria—Capecitabine—kidney cancer	0.000155	0.00106	CcSEcCtD
Methoxsalen—Body temperature increased—Capecitabine—kidney cancer	0.000155	0.00106	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—kidney cancer	0.000154	0.00106	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—kidney cancer	0.000152	0.00104	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—kidney cancer	0.000151	0.00103	CcSEcCtD
Methoxsalen—Rash—Paclitaxel—kidney cancer	0.00015	0.00103	CcSEcCtD
Methoxsalen—Dermatitis—Paclitaxel—kidney cancer	0.00015	0.00103	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—kidney cancer	0.00015	0.00103	CcSEcCtD
Methoxsalen—Headache—Paclitaxel—kidney cancer	0.000149	0.00102	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—kidney cancer	0.000148	0.00102	CcSEcCtD
Methoxsalen—Hypersensitivity—Capecitabine—kidney cancer	0.000144	0.000985	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—kidney cancer	0.000143	0.00098	CcSEcCtD
Methoxsalen—Nausea—Paclitaxel—kidney cancer	0.000141	0.000968	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—kidney cancer	0.000139	0.000952	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—kidney cancer	0.000139	0.000949	CcSEcCtD
Methoxsalen—Pruritus—Capecitabine—kidney cancer	0.000138	0.000946	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—kidney cancer	0.00013	0.000888	CcSEcCtD
Methoxsalen—Dizziness—Capecitabine—kidney cancer	0.000129	0.000884	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—kidney cancer	0.000126	0.000862	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—kidney cancer	0.000125	0.000856	CcSEcCtD
Methoxsalen—Rash—Capecitabine—kidney cancer	0.000123	0.000843	CcSEcCtD
Methoxsalen—Dermatitis—Capecitabine—kidney cancer	0.000123	0.000842	CcSEcCtD
Methoxsalen—Headache—Capecitabine—kidney cancer	0.000122	0.000838	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—kidney cancer	0.000122	0.000837	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—kidney cancer	0.000118	0.000805	CcSEcCtD
Methoxsalen—Nausea—Capecitabine—kidney cancer	0.000116	0.000794	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—kidney cancer	0.000114	0.00078	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—kidney cancer	0.000111	0.000759	CcSEcCtD
Methoxsalen—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	0.00011	0.00157	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	0.000109	0.00157	CbGpPWpGaD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000109	0.000744	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TP53—kidney cancer	0.000108	0.00155	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000107	0.00154	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000107	0.00153	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GSTP1—kidney cancer	0.000107	0.00153	CbGpPWpGaD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000105	0.00151	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000104	0.00149	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.000104	0.00149	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Doxorubicin—kidney cancer	0.000104	0.00071	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—CRABP1—kidney cancer	0.000102	0.00146	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTT1—kidney cancer	0.000101	0.00144	CbGpPWpGaD
Methoxsalen—Urticaria—Doxorubicin—kidney cancer	0.0001	0.000685	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—kidney cancer	9.96e-05	0.000681	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	9.84e-05	0.00141	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	9.84e-05	0.00141	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GSTM1—kidney cancer	9.82e-05	0.00141	CbGpPWpGaD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—PTGS2—kidney cancer	9.72e-05	0.00139	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	9.63e-05	0.00138	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ITPR2—kidney cancer	9.45e-05	0.00136	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—PTGS1—kidney cancer	9.44e-05	0.00135	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—GSTP1—kidney cancer	9.37e-05	0.00134	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	9.37e-05	0.00134	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Doxorubicin—kidney cancer	9.28e-05	0.000635	CcSEcCtD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.01e-05	0.00129	CbGpPWpGaD
Methoxsalen—Pruritus—Doxorubicin—kidney cancer	8.91e-05	0.00061	CcSEcCtD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.89e-05	0.00127	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.75e-05	0.00125	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ACHE—kidney cancer	8.62e-05	0.00124	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTT1—kidney cancer	8.62e-05	0.00124	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—GSTM1—kidney cancer	8.61e-05	0.00123	CbGpPWpGaD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.6e-05	0.00123	CbGpPWpGaD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.54e-05	0.00122	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	8.44e-05	0.00121	CbGpPWpGaD
Methoxsalen—Dizziness—Doxorubicin—kidney cancer	8.33e-05	0.00057	CcSEcCtD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.33e-05	0.00119	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	8.19e-05	0.00117	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP1A1—kidney cancer	8.17e-05	0.00117	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—SCARB1—kidney cancer	8.16e-05	0.00117	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTGS1—kidney cancer	8.08e-05	0.00116	CbGpPWpGaD
Methoxsalen—Rash—Doxorubicin—kidney cancer	7.94e-05	0.000543	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—kidney cancer	7.94e-05	0.000543	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—PSMD7—kidney cancer	7.92e-05	0.00114	CbGpPWpGaD
Methoxsalen—Headache—Doxorubicin—kidney cancer	7.89e-05	0.00054	CcSEcCtD
Methoxsalen—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	7.61e-05	0.00109	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—kidney cancer	7.53e-05	0.00108	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—BCHE—kidney cancer	7.51e-05	0.00108	CbGpPWpGaD
Methoxsalen—Nausea—Doxorubicin—kidney cancer	7.48e-05	0.000512	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—SLC5A5—kidney cancer	7.42e-05	0.00106	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	7.37e-05	0.00106	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.3e-05	0.00105	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ACY1—kidney cancer	7.18e-05	0.00103	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—SLC2A1—kidney cancer	7.16e-05	0.00103	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	6.99e-05	0.001	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTP1—kidney cancer	6.98e-05	0.001	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	6.96e-05	0.000998	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.95e-05	0.000997	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GSTP1—kidney cancer	6.89e-05	0.000987	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.86e-05	0.000984	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	6.85e-05	0.000982	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	6.82e-05	0.000978	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.72e-05	0.000963	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	6.63e-05	0.00095	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTT1—kidney cancer	6.42e-05	0.000921	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTM1—kidney cancer	6.42e-05	0.00092	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GSTM1—kidney cancer	6.33e-05	0.000907	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	6.28e-05	0.0009	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	6.28e-05	0.0009	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	6.2e-05	0.000889	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	6.14e-05	0.00088	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PDHB—kidney cancer	6.11e-05	0.000875	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—POMC—kidney cancer	6.09e-05	0.000873	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—PTGS1—kidney cancer	6.02e-05	0.000863	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTP1—kidney cancer	5.98e-05	0.000857	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	5.97e-05	0.000856	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CCBL1—kidney cancer	5.74e-05	0.000823	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ABCB1—kidney cancer	5.66e-05	0.000811	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.64e-05	0.000808	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTM1—kidney cancer	5.49e-05	0.000787	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.44e-05	0.000781	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ACY1—kidney cancer	5.35e-05	0.000767	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.31e-05	0.000761	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	5.22e-05	0.000748	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP1A1—kidney cancer	5.21e-05	0.000746	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.18e-05	0.000743	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GLIPR1—kidney cancer	4.98e-05	0.000714	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPAT—kidney cancer	4.98e-05	0.000714	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.96e-05	0.000711	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	4.8e-05	0.000688	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	4.7e-05	0.000673	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.65e-05	0.000666	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—APRT—kidney cancer	4.63e-05	0.000663	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—FH—kidney cancer	4.63e-05	0.000663	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.56e-05	0.000654	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PDHB—kidney cancer	4.55e-05	0.000652	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—POMC—kidney cancer	4.54e-05	0.00065	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTP1—kidney cancer	4.45e-05	0.000638	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	4.44e-05	0.000636	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	4.39e-05	0.00063	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GPC3—kidney cancer	4.35e-05	0.000624	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CCBL1—kidney cancer	4.28e-05	0.000613	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CA2—kidney cancer	4.23e-05	0.000607	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.2e-05	0.000602	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ALAD—kidney cancer	4.13e-05	0.000591	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTM1—kidney cancer	4.09e-05	0.000587	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	4.04e-05	0.000579	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ST3GAL2—kidney cancer	4.03e-05	0.000577	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ALDH1A1—kidney cancer	3.94e-05	0.000564	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—POMC—kidney cancer	3.88e-05	0.000556	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	3.88e-05	0.000556	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.87e-05	0.000555	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.83e-05	0.000548	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PGK1—kidney cancer	3.77e-05	0.000541	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SLC5A3—kidney cancer	3.77e-05	0.000541	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPAT—kidney cancer	3.71e-05	0.000532	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GLIPR1—kidney cancer	3.71e-05	0.000532	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—LDHB—kidney cancer	3.7e-05	0.00053	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.66e-05	0.000525	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.63e-05	0.00052	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—FH—kidney cancer	3.45e-05	0.000494	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—APRT—kidney cancer	3.45e-05	0.000494	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.44e-05	0.000493	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACY1—kidney cancer	3.41e-05	0.000489	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.39e-05	0.000486	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.37e-05	0.000483	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GPC3—kidney cancer	3.24e-05	0.000465	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CA9—kidney cancer	3.21e-05	0.00046	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.16e-05	0.000453	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CA2—kidney cancer	3.15e-05	0.000452	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.11e-05	0.000446	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTGS2—kidney cancer	3.1e-05	0.000444	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ALAD—kidney cancer	3.07e-05	0.000441	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ST3GAL2—kidney cancer	3e-05	0.00043	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.99e-05	0.000429	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.95e-05	0.000423	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ALDH1A1—kidney cancer	2.93e-05	0.00042	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.91e-05	0.000417	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PDHB—kidney cancer	2.9e-05	0.000416	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—POMC—kidney cancer	2.89e-05	0.000415	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PGK1—kidney cancer	2.81e-05	0.000403	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC5A3—kidney cancer	2.81e-05	0.000403	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—LDHB—kidney cancer	2.76e-05	0.000395	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CCBL1—kidney cancer	2.73e-05	0.000391	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CRABP1—kidney cancer	2.73e-05	0.000391	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTEN—kidney cancer	2.7e-05	0.000387	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACY1—kidney cancer	2.63e-05	0.000377	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ITPR2—kidney cancer	2.54e-05	0.000364	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.47e-05	0.000354	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CA9—kidney cancer	2.39e-05	0.000343	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPAT—kidney cancer	2.37e-05	0.000339	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.37e-05	0.000339	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.34e-05	0.000335	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTT1—kidney cancer	2.31e-05	0.000332	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ACHE—kidney cancer	2.31e-05	0.000332	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.31e-05	0.000331	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PDHB—kidney cancer	2.24e-05	0.000321	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—POMC—kidney cancer	2.23e-05	0.00032	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—FH—kidney cancer	2.2e-05	0.000315	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—APRT—kidney cancer	2.2e-05	0.000315	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SCARB1—kidney cancer	2.19e-05	0.000314	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTGS1—kidney cancer	2.17e-05	0.000311	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.15e-05	0.000308	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PSMD7—kidney cancer	2.13e-05	0.000305	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CCBL1—kidney cancer	2.11e-05	0.000302	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GPC3—kidney cancer	2.07e-05	0.000296	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CRABP1—kidney cancer	2.03e-05	0.000291	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—BCHE—kidney cancer	2.01e-05	0.000289	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CA2—kidney cancer	2.01e-05	0.000288	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.99e-05	0.000285	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALAD—kidney cancer	1.96e-05	0.000281	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.92e-05	0.000276	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.91e-05	0.000274	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PIK3CA—kidney cancer	1.9e-05	0.000273	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ITPR2—kidney cancer	1.89e-05	0.000271	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.87e-05	0.000268	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.83e-05	0.000262	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPAT—kidney cancer	1.83e-05	0.000262	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PGK1—kidney cancer	1.79e-05	0.000257	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.79e-05	0.000257	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LDHB—kidney cancer	1.76e-05	0.000252	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.74e-05	0.00025	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTT1—kidney cancer	1.72e-05	0.000247	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ACHE—kidney cancer	1.72e-05	0.000247	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—APRT—kidney cancer	1.7e-05	0.000243	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—FH—kidney cancer	1.7e-05	0.000243	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SCARB1—kidney cancer	1.63e-05	0.000234	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTGS1—kidney cancer	1.61e-05	0.000231	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTP1—kidney cancer	1.6e-05	0.00023	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPC3—kidney cancer	1.6e-05	0.000229	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PSMD7—kidney cancer	1.58e-05	0.000227	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CA2—kidney cancer	1.55e-05	0.000222	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CA9—kidney cancer	1.52e-05	0.000218	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ABCB1—kidney cancer	1.52e-05	0.000218	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALAD—kidney cancer	1.51e-05	0.000217	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—BCHE—kidney cancer	1.5e-05	0.000215	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.49e-05	0.000214	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.48e-05	0.000213	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.48e-05	0.000212	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTM1—kidney cancer	1.47e-05	0.000211	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.44e-05	0.000207	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.43e-05	0.000205	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.4e-05	0.0002	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.39e-05	0.000199	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PGK1—kidney cancer	1.38e-05	0.000198	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.38e-05	0.000198	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LDHB—kidney cancer	1.36e-05	0.000194	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CRABP1—kidney cancer	1.3e-05	0.000186	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.21e-05	0.000174	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ITPR2—kidney cancer	1.2e-05	0.000173	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000171	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CA9—kidney cancer	1.18e-05	0.000169	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ABCB1—kidney cancer	1.13e-05	0.000162	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.11e-05	0.000159	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACHE—kidney cancer	1.1e-05	0.000157	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTT1—kidney cancer	1.1e-05	0.000157	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTM1—kidney cancer	1.1e-05	0.000157	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—POMC—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SCARB1—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTGS1—kidney cancer	1.03e-05	0.000148	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PSMD7—kidney cancer	1.01e-05	0.000145	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CRABP1—kidney cancer	1e-05	0.000143	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—BCHE—kidney cancer	9.57e-06	0.000137	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.45e-06	0.000136	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ITPR2—kidney cancer	9.3e-06	0.000133	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC2A1—kidney cancer	9.13e-06	0.000131	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.86e-06	0.000127	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.55e-06	0.000123	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTT1—kidney cancer	8.48e-06	0.000122	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACHE—kidney cancer	8.48e-06	0.000122	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTGS2—kidney cancer	8.3e-06	0.000119	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SCARB1—kidney cancer	8.03e-06	0.000115	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGS1—kidney cancer	7.95e-06	0.000114	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PSMD7—kidney cancer	7.79e-06	0.000112	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—POMC—kidney cancer	7.76e-06	0.000111	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.73e-06	0.000111	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTP1—kidney cancer	7.62e-06	0.000109	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—BCHE—kidney cancer	7.39e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.3e-06	0.000105	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTEN—kidney cancer	7.24e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ABCB1—kidney cancer	7.21e-06	0.000103	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.05e-06	0.000101	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTM1—kidney cancer	7e-06	0.0001	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.63e-06	9.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTGS2—kidney cancer	6.19e-06	8.87e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTP1—kidney cancer	5.88e-06	8.42e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ABCB1—kidney cancer	5.56e-06	7.97e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.45e-06	7.81e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTM1—kidney cancer	5.4e-06	7.74e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTEN—kidney cancer	5.4e-06	7.74e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.12e-06	7.34e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CA—kidney cancer	5.11e-06	7.32e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—POMC—kidney cancer	4.95e-06	7.09e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTGS2—kidney cancer	3.95e-06	5.66e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—POMC—kidney cancer	3.82e-06	5.47e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CA—kidney cancer	3.81e-06	5.46e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTEN—kidney cancer	3.44e-06	4.93e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGS2—kidney cancer	3.04e-06	4.36e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTEN—kidney cancer	2.66e-06	3.81e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.43e-06	3.48e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.87e-06	2.69e-05	CbGpPWpGaD
